Capstone Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
16,571
+11,287
| +214% | +$936K | ﹤0.01% | 346 |
|
|
2025
Q1 | $429K | Sell |
5,284
-7,621
| -59% | -$618K | ﹤0.01% | 431 |
|
|
2024
Q4 | $1.16M | Buy |
+12,905
| New | +$1.16M | ﹤0.01% | 348 |
|
|
2024
Q3 | – | Sell |
-29,898
| Closed | -$2.77M | – | 1172 |
|
|
2024
Q2 | $2.77M | Buy |
+29,898
| New | +$2.77M | 0.01% | 178 |
|
|
2023
Q4 | – | Sell |
-30,403
| Closed | -$2.22M | – | 1429 |
|
|
2023
Q3 | $2.22M | Buy |
30,403
+24,468
| +412% | +$1.79M | 0.01% | 267 |
|
|
2023
Q2 | $494K | Sell |
5,935
-2,611
| -31% | -$217K | ﹤0.01% | 446 |
|
|
2023
Q1 | $651K | Buy |
8,546
+3,800
| +80% | +$290K | ﹤0.01% | 312 |
|
|
2022
Q4 | $394K | Buy |
+4,746
| New | +$394K | ﹤0.01% | 480 |
|
|
2022
Q1 | – | Sell |
-88,138
| Closed | -$9.87M | – | 1169 |
|
|
2021
Q4 | $9.87M | Buy |
88,138
+40,365
| +84% | +$4.52M | 0.02% | 138 |
|
|
2021
Q3 | $6.01M | Buy |
47,773
+32,573
| +214% | +$4.1M | 0.01% | 190 |
|
|
2021
Q2 | $2.06M | Buy |
+15,200
| New | +$2.06M | ﹤0.01% | 232 |
|